| acquired immunodeficiency syndrome | AIDS |
| antioxidant response element | ARE |
| antiretrovirals | ARVs |
| Catalase | CAT |
| Complementary deoxyribonucleic acid | cDNA |
| Complete culture media | CCM |
| distilled water | dH2O |
| Eagle’s Essential Minimal Media | EMEM |
| Emtricitabine/2′,3′-dideoxy-5fluoro-3′-thiacytidine | FTC |
| Endothelial nitric oxide synthase | eNOS |
| Glyceraldehyde 3-phosphate dehydrogenase | GAPDH |
| highly active antiretroviral therapy | HAART |
| human immunodeficiency virus | HIV |
| Human hepatoma/Human liver cells | HepG2 |
| horseradish peroxidase | HRP |
| hydroxyl | OH· |
| hydrogen peroxide | H2O2 |
| inducible NO synthase | iNOS |
| tenofovir disoproxil fumarate | TDF |
| Kelch-like ECH-associated protein 1 | Keap1 |
| Lamivudine/(-)-L-2′,3′-dideoxy-3′-thiacytidine | 3TC |
| Messenger RNA | mRNA |
| nuclear factor erythroid 2-related factor 2 | NRF-2 |
| nucleoside/nucleotide reverse transcriptase inhibitors | NRTIs |
| NADH quinone oxidoreductase 1 | NQO-1 |
| NADPH oxidase | NOX |
| nitric oxide | NO· |
| Nuclear Magnetic Resonance | NMR |
| One-way analysis of variance | ANOVA |
| Phosphate buffered saline | PBS |
| phosphorylated NRF-2 | pNRF-2 |
| potential exposure prophylaxis | PEP |
| Pre-exposure prophylaxis | PrEP |
| protein kinase B | Akt |
| Quantitative polymerase chain reaction | qPCR |
| Reactive oxygen species | ROS |
| relative band density | RBD |
| ribonucleic acid | RNA |
| room temperature | RT |
| Spirulina platensis | SP |
| Sodium dodecyl sulphide | SDS |
| tenofovir disoproxil fumarate | TDF |
| World Health Organization | WHO |